Figures & data
Table I. Clinical characteristics of the index patients with hypertrophic cardiomyopathy.
Table II. Frequencies of the mutations TPM1-D175N and MYBPC3-Q1061X according to study center.
Figure 1. Prevalence of the mutations TPM1 (alpha-tropomyosin)-D175N and MYBPC3 (cardiac myosin-binding protein C)-Q1061X in the five largest study centers (Helsinki, Tampere, Kuopio, Jyväskylä, and Seinäjoki). Hospital districts are numbered (Citation1–12) corresponding to the numbers in .
![Figure 1. Prevalence of the mutations TPM1 (alpha-tropomyosin)-D175N and MYBPC3 (cardiac myosin-binding protein C)-Q1061X in the five largest study centers (Helsinki, Tampere, Kuopio, Jyväskylä, and Seinäjoki). Hospital districts are numbered (Citation1–12) corresponding to the numbers in Table II.](/cms/asset/7c95796f-8979-44ad-a1a3-aa876d070d03/iann_a_671534_f0001_b.gif)